Home
Business
Corporate Finance
Asset Management
Wealth Management
Sales, Trading, and Research
Structured Finance
Research
Daily Note
Market Strategy
Macroeconomics
Securities Analysis
Customer Trading
Stock Trading
Futures Trading
ESOP
Company News
About CMBI
Company Profile
Join Us
Contact Us
English
Simplified Chinese
Traditional Chinese
English
Company News
Home
>
Company News
2021
02-26
CMBI acted as Joint Bookrunner for the Hong Kong IPO of JOINN Laboratories (China) Co., Ltd. (6127.HK)
2021
01-19
CMBI acted as Joint Bookrunner for the Hong Kong IPO of Strawbear Entertainment Group (2251.HK)
2020
11-20
CMBI acted as Joint Bookrunner Joint Bookrunner and Joint Lead Manager for the Hong Kong IPO of Antengene Corporation Limited (6996.HK)
2020
10-27
CMBI acted as Joint Bookrunner for the Hong Kong IPO of Simcere Pharmaceutical Group Limited. (2096.HK)
2020
09-29
CMBI Acted as Joint Sponsor for the Hong Kong Secondary Listing of Baozun (9991.HK)
2020
09-10
CMBI acted as Joint Global Coordinator (the only Chinese JGC), Joint Bookrunner and Joint lead manager for the HK secondary listing of Yum China (9987.HK)
2020
07-08
CMBI acted as Joint Global Coordinator, Joint Bookrunner and Joint lead manager for the H-share IPO of Shenzhen Hepalink Pharmaceutical Group Co., Ltd.(9989.HK)
2020
06-18
CMBI acted as Joint Bookrunner and Joint Lead Manager for the US$3.9 billion HK secondary listing of JD.com, Inc. (9618.HK)
2020
06-11
CMBI acted as Joint Bookrunner and Joint Lead Manager for the US$2.7 billion HK secondary listing of NetEase, Inc. (9999.HK)
2020
05-22
CMBI acted as Joint Bookrunner for the Hong Kong IPO of Kintor Pharmaceutical Limited (9939.HK)
1
2
3
4
5
Next
